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Resistance against antimicrobial peptides (AMPs) is often mediated by detoxification 
modules that rely on sensing the AMP through a BceAB-like ATP-binding cassette (ABC) 
transporter that subsequently activates a cognate two-component system (TCS) to mount 
the cell response. Here, the Lactococcus lactis ABC transporter YsaDCB is shown to 
constitute, together with TCS-G, a detoxification module that protects L. lactis against 
bacitracin and the bacteriocin Lcn972, both AMPs that inhibit cell wall biosynthesis. Initially, 
increased expression of ysaDCB was detected by RT-qPCR in three L. lactis resistant to 
Lcn972, two of which were also resistant to bacitracin. These mutants shared, among 
others, single-point mutations in ysaB coding for the putative Bce-like permease. These 
results led us to investigate the function of YsaDCB ABC-transporter and study the impact 
of these mutations. Expression in trans of ysaDCB in L. lactis NZ9000, a strain that lacks 
a functional detoxification module, enhanced resistance to both AMPs, demonstrating its 
role as a resistance factor in L. lactis. When the three different ysaB alleles from the 
mutants were expressed, all of them outperformed the wild-type transporter in resistance 
against Lcn972 but not against bacitracin, suggesting a distinct mode of protection against 
each AMP. Moreover, PysaD promoter fusions, designed to measure the activation of the 
detoxification module, revealed that the ysaB mutations unlock transcriptional control by 
TCS-G, resulting in constitutive expression of the ysaDCB operon. Finally, deletion of ysaD 
was also performed to get an insight into the function of this gene. ysaD encodes a 
secreted peptide and is part of the ysaDCB operon. YsaD appears to modulate signal 
relay between the ABC transporter and TCS-G, based on the different response of the 
PysaD promoter fusions when it is not present. Altogether, the results underscore the unique 
features of this lactococcal detoxification module that warrant further research to advance 
in our overall understanding of these important resistance factors in bacteria.
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INTRODUCTION
ATP-binding cassette (ABC) transporters are bacterial efflux 
pumps that mediate transport across the membrane at the 
expenses of the energy liberated by the hydrolysis of ATP 
(Du et  al., 2018). They are constituted by a transmembrane 
domain (TMD) with a substrate-binding pocket and the 
nucleotide-binding domain (NBD) that alternate between two 
structural conformations, inward-open and outward-open, to 
translocate substrates. ABC transporters are functionally diverse 
and participate in bacterial virulence, quorum sensing, nutrient 
uptake, or export of toxic molecules. In particular, ABC 
transporters are regarded as the fastest-acting and very effective 
resistance mechanisms to many antimicrobials (Du et  al., 
2018). Moreover, their role as sensors and information 
processors in signal relay is being increasingly recognized 
(Piepenbreier et  al., 2017).
In Firmicutes, some ABC transporters confer resistance 
to antimicrobial peptides (AMPs) including peptide antibiotics 
(e.g., bacitracin), host antimicrobial peptides (e.g., LL-37 and 
hBD3 defensins), and bacteriocins (e.g., nisin). Based on their 
domain architecture and phylogenetic relationships, five groups 
have been established (Gebhard, 2012). Two of them are 
required for the export of newly synthesized AMPs (SunT 
and NisT type) and three are involved in resistance (LanFEG, 
BceAB, and BcrAB type). BceAB-type transporters are 
characterized by the NBD protein BceA and the permease 
BceB with 10 transmembrane helices (TMH) and a large 
extracellular loop (ECL) between TMH-VII and VIII. Many 
BceAB-type transporters are genetically and functionally linked 
to two component systems (TCS), involved in signal 
transduction and gene regulation. Actually, the Bce-type 
permeases and the histidine kinases of the cognate TCS have 
coevolved toward functional AMP detoxification modules 
(Dintner et al., 2011). Moreover, the histidine kinases of these 
TCSs are intramembrane-sensing kinases that completely rely 
on the ABC transporter to sense the AMP (Bernard et  al., 
2007). One of the best-characterized detoxification modules 
is BceRS-BceAB involved in resistance of Bacillus subtilis to 
bacitracin. The BceAB transporter actively participates in 
bacitracin resistance, likely by freeing its target from the 
antibiotic grip (Kobras et  al., 2020), and interacts directly 
with the histidine kinase BceS to form a sensory complex 
that controls the expression of bceAB (Dintner et  al., 2014). 
This detoxification module responds to a novel signaling 
mechanism, so-called flux sensing, whereby monitoring the 
activity of the individual ABC transporters is the cue to 
activating the cognate TCS and triggering the cell response 
(Fritz et  al., 2015).
The role of BceAB-type transporters in sensing, together 
with their role in detoxification, has prompted their classification 
into three main functional groups proposed by Revilla-Guarinos 
et al. (2014): (i) those with a dual function involved in sensing 
and resistance (e.g., BceAB, ABC09 of Lactobacillus casei); 
(ii)  sensing transporters that trigger the response but are 
unable  to  confer resistance on their own (e.g., VraFG that 
activates  the  GraXSR TCS in Staphylococcus aureus); and 
(iii) standalone detoxification pumps which are often regulated 
by a nongenetically linked TCS (e.g., VraDEH of S. aureus).
Additional or accessory components within the ABC/TCS 
resistance modules may also be  present and are thought to 
be  involved in fine tuning both signaling and transport 
activities. The cytosolic protein GraX from the TCS GraXRS 
of S. aureus has been shown to interact with the histidine 
kinase GraS, and it is required for GraR-gene activation 
(Falord et  al., 2012). Likewise, vraH, located downstream in 
the vraDEH operon, encodes a small membrane protein, 
which is required for high-resistance to daptomycin and 
gallidermin (Popella et al., 2016). Other protecting mechanisms 
may also cluster with ABC/TCS detoxification modules. In 
Streptococcus agalactiae, the module NsrFP/NsrKR involved 
in nisin resistance is complemented with the nisin resistance 
protein Nsr, a nisin-degrading protease (Khosa et  al., 2013; 
Reiners et  al., 2017).
In a previous work, we have carried out adaptive evolution 
experiments with several Lactococcus lactis strains, which 
are  used worldwide as starters in milk fermentation 
(López-González et al., 2018). These strains were grown under 
the selective pressure exerted by the bacteriocin Lcn972, a 
class IId bacteriocin that binds to lipid II and inhibits cell 
wall biosynthesis, triggering the cell envelope stress response 
in Lactococcus (Martínez et  al., 2007, 2008). The preliminary 
insight into the genome of these mutants resistant to Lcn972 
revealed that, among others, non-synonymous mutations often 
occurred in a putative Bce-like detoxification module, comprised 
by an ABC transporter (YsaDCB) and an adjacent TCS 
(TCS-G) (López-González et  al., 2018). Precisely, three of 
these mutants shared mutations in ysaB, coding for a BceB-
like permease and two of them were also resistant to bacitracin. 
These observations prompted us to hypothesize that the 
YsaDCB ABC transporter might be part of a Bce-like resistance 
module in L. lactis. Therefore, we  set out to determine the 
role of YsaDCB in resistance to bacitracin and Lcn972 and 
to investigate the consequences of the ysaB mutations. The 
results show that L. lactis YsaDCB is involved in both sensing 
and resistance to AMPs and that those mutations in ysaB 
may impair either function. Moreover, YsaDCB is shown to 
protect against bacitracin and Lcn972 by a distinct mode of 
action. Finally, the secreted peptide YsaD is proposed to 
modulate signal transduction between the ABC transporter 
and the histidine kinase of TCS-G.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
L. lactis strains used in this work and their main characteristics 
are listed in Table  1. The wild-type (WT) L. lactis L81 and 
L62 and their Lcn972R mutants L81-D1, L81-E2, and L62-G9 
were grown at 30°C in M17 with lactose at 0.5% (LM17). 
For the plasmid-free laboratory strains L. lactis IL1403 and 
L. lactis NZ9000, glucose at 0.5% was used (GM17). Antibiotics 
chloramphenicol (Cm), erythromycin (Em), and tetracycline 
(Tet) were added at 5  μg/ml depending on the plasmid 
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(Table  1) and the same concentrations were  used when two 
plasmids were present in the same lactococcal cell.
Antimicrobial Susceptibility Tests
Minimum inhibitory concentrations (MICs) were determined by 
the broth dilution method in microtiter plates as previously described 
(López-González et al., 2018). Two-fold dilutions of the antimicrobials 
to be tested (bacitracin, nisin, and vancomycin) were done in GM17 
or LM17 broth depending on the lactococcal strain. Plates were 
inoculated with exponentially growing cells adjusted to an optical 
density at 600  nm (OD600) of 0.05, and then further diluted 1/100. 
Susceptibility of the L. lactis NZ9000 clones carrying the expression 
plasmids pDCB_n and pCB_n (Table  1) was scored according to 
the inhibitory concentration able to inhibit growth by 50% (IC50). 
IC50 was determined essentially as described by Reiners et al. (2017). 
IC50 plates were inoculated with overnight cultures adjusted to an 
OD600 of 0.1. For gene expression, 1  ng/ml of nisin was routinely 
added to both pre-cultures and IC50 determinations.
RNA Extraction and Analysis
Three independent cultures of L. lactis L81, L. lactis L62, and 
their Lcn972R mutants (Table  1) were grown on LM17 at 
30°C until they reached an OD600 of 1.0, when RNAprotect 
Bacteria Reagent (Qiagen, Germany) was added. Total RNA 
was extracted using the Illustra RNAspin Mini Kit (GE Healthcare, 
UK) and treated with Turbo DNAse (Ambion) and SUPERase 
RNase Inhibitor (Ambion). RNA quality was checked by agarose 
gel electrophoresis, and its concentration was determined by 
absorbance at 260 nm in an Epoch microplate spectrophotometer 
(BioTek). One microgram of each RNA sample was used to 
generate cDNA with the iScript cDNA Synthesis Kit (Bio-Rad 
Laboratories, Hercules, CA).
RT-qPCR was performed in a 7500 Fast Real-Time PCR 
System (Applied Biosystems, Warrington, UK). Primers used 
for RT-qPCR are listed in Supplementary Table  1 and were 
supplied by Macrogen (Korea). Amplification was carried out 
in 25 μl containing 2.5 μl of a 1:25 dilution of cDNA, 1× Power 
SYBR Green (Applied Biosystems), and each primer at a 
concentration of 0.2 μM. Each cDNA amplification was repeated 
in duplicate. After incubation at 95°C for 10 min, amplification 
proceeded with 40 cycles of 95°C for 15 s and 60°C for 1 min. 
Fold changes were calculated following the 2−Δ∆Ct method (Livak 
and Schmittgen, 2001), and the reference gene was the elongation 
factor Tu tuf.
PCR reactions to identify transcription units were performed 
in a MyCycler Thermal Cycler (Bio-Rad Laboratories). Primers 
are listed in Supplementary Table  1. PCR reactions were 
carried out in a final volume of 25  μl containing 1  μl of 
cDNA, 1× Taq DNA Polymerase Master Mix Red (Ampliqon, 
Denmark) and each primer at a concentration of 0.2 μM. PCR 
amplification conditions were as follows: 1 cycle at 95°C for 
4  min followed by 30 cycles at 95°C for 30  s, 50°C for 30  s, 
and 72°C for 30  s and a final cycle at 72°C for 7  min. PCR 
controls were carried with either RNA or genomic DNA. PCR 
products were analyzed by 2% agarose gel electrophoresis.
pDCB and pCB Expression Plasmids
All the primers required for plasmid construction are listed 
in Supplementary Table 1. Restriction enzymes and T4 ligase 
were supplied by Eurofins Genomics (Germany) and Fisher 
Scientific (Spain), respectively, and used according to the 
manufacturer’s instructions. Commercial kits were used for 
purification of chromosomal DNA (GenElute Bacterial Genomic 
DNA Kit, Sigma, Spain), plasmids (High Pure Plasmid Isolation 
Kit, Roche, Germany), and DNA fragments using Illustra 
GFX PCR DNA and Gel Band Purification Kit (GE Healthcare, 
UK). The expression plasmids were based on pUK200, placing 
the ysaDCB and ysaCB genes under the control of the 
inducible nisin promoter to yield the plasmids pDCB_n and 
pCB_n (Table  1), tagged after the source of the ysa genes 
as pDCB_IL (IL1403), pDCB_L81, pDCB_D1, pDCB_E2, 
pDCB_G9, pCB_IL, and pCB_L81. The genes were amplified 
by PCR with Pwo SuperYield polymerase (Roche, Spain) 
using as template genomic DNA from L. lactis strains IL1403, 
L81, D1, E2, and G9 and annealing T of 58°C. PCR products 
TABLE 1 | Bacterial strains and plasmids used in this study.
Strain Propertiesa Reference
L. lactis subsp. lactis
L81





Lcn972R from L81, ysaB 
mutation F577S, P605T
L81-E2
Lcn972R from L81, ysaB 
mutation F577V
L62
WT strain, commercial 
starter culture
L62-G9
Lcn972R from L62, ysaB 
mutation I594F
IL1403
Laboratory strain, plasmid 
free
Bolotin et al. (2001)
L. lactis subsp. cremoris
NZ9000 Host for nisin-inducible 
















pILG Based on pIL252. EmR Campelo et al. (2010)
pDCB_n
ysaDCB genes in 




ysaCB genes in pUK200, 
“n” stands for strain origin
This work
pPysaD::lacZ








ysaDIL promoter fused to 
mrfp in pILG
This work
aWT, wild-type; Cm, chloramphenicol; Tet, tetracycline; Em, erythromycin. L81-D1, 
L81-E2, and L62-G9 carry several mutations (López-González et al., 2018), but only 
those in ysaB are specified.
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TABLE 2 | Minimum inhibitory concentrations (MICs) of several antimicrobial 











L81 (WT) 10 8 0.5 1
L81-D1 80 4 0.5 2
L81-E2 320 64 0.5 4
L62 (WT) 10 8 0.5 2
L62-G9 80 32 1 4
IL1403 40 0.125 0.5 ND
NZ9000 20 0.5 0.5 ND
aTaken from López-González et al. (2018).
bND, not determined.
were digested with RcaI and BamHI in the case of the 
pDCB_n plasmids and with NcoI and BamHI for the pCB_n 
plasmids. After digestion, the DNA fragments were ligated 
into pUK200 cut with NcoI and BamHI. The resulting plasmids 
were established into L. lactis NZ9000 by electroporation 
and checked by DNA sequencing (Macrogen, Spain) to confirm 
proper cloning.
PysaD Reporter Plasmids
The β-galactosidase reporter plasmid pPysaD::lacZ was based on 
pPTPL (Table  1). The promoter PysaD was amplified by PCR 
using Pwo SuperYield polymerase (Roche, Spain) and the 
primers described in Supplementary Table  1. As template, 
genomic DNA from L. lactis IL1403 was used since the upstream 
ysaD DNA sequence was identical in L. lactis IL1403, L81, 
and L62. The PCR product and the vector were digested by 
EcoRI and XbaI, ligated, and electroporated into L. lactis 
NZ9000. Two fluorescent reporter plasmids harboring the mrfp 
gene coding for mCherry were constructed (Table  1). pRCR_
PysaD::mrfp was based on pRCR (Table  1). The PCR-amplified 
PysaD promoter was digested with XbaI only to leave the 5' 
end blunt and ligated into SmaI-XbaI-digested pRCR. Escherichia 
coli DH10B (Invitrogen) was used as an intermediate host for 
cloning. The plasmid was introduced into L. lactis strains IL1403 
and NZ9000 and the lactose positive L. lactis L81, L81-D1, 
and L81-E2 by electroporation. The BglII-SacI DNA fragment 
encompassing the PysaD::mrpf fusion from pRCR_PysaD::mrfp was 
excised and cloned into pILG, digested with the same restriction 
enzymes to yield pIL_PysaD::mrfp (Table 1). This plasmid carries 
an erythromycin resistance marker, which made possible to 
maintain the reporter plasmid together with pDCB_n and 
pCB_n expression plasmids (CmR) in the same cell. Correct 
cloning was confirmed by DNA sequencing (Macrogen, Spain).
Activity of the PysaD Promoter With the 
Reporter Plasmid pPysaD::lacZ
Fresh overnight cultures of L. lactis NZ9000 clones carrying the 
different expression plasmids pDCB_n and pCB_n and the reporter 
plasmid pPysaD::lacZ were diluted to OD600 of 0.05  in GM17/Cm/
Tet and nisin at 1  ng/ml to ensure expression of the ysa genes. 
When the clones reached an OD600 of 0.2–0.3 (approximately 
3  h at 30°C), 2  ml samples were taken and bacitracin was added 
at 5 and 1  μg/ml and incubation proceeded for 30  min. Cultures 
without bacitracin were taken as baseline controls. Cells were 
collected by centrifugation, and the β-galactosidase reaction was 
carried out at 30°C for 10  min as described elsewhere (Martínez 
et  al., 2007). β-Galactosidase activity assays were carried out, at 
least, with three independent cultures.
Activity of the PysaD Promoter With the 
Reporter Plasmid pIL_PysaD::mrfp
L. lactis NZ9000 pDCB_n and pCB_n and the reporter 
plasmid pIL_PysaD::mrfp were inoculated in GM17/Cm/Em 
and 1  ng/ml nisin and grown as described for pPysaD::LacZ. 
After induction with bacitracin (1 and 5  μg/ml) or Lcn972 
(80, 40, and 20  AU/ml), cells (1  ml) were washed with 
saline phosphate buffer (PBS), pH 7.3, and collected in half 
of the initial volume. Cell suspensions were kept in the 
dark for 3  h for mCherry maturation (Garay-Novillo 
et al., 2019). Fluorescence (F) of 20-μl aliquots was quantified 
in a 7500 Fast Real-Time PCR System (Applied Biosystems, 
Warrington, UK) using the built-in presence/absence protocol 
for detecting ROX, a fluorophore with similar excitation 
(Ex. 580  nm) and emission (Em. 605  nm) wavelengths as 
mCherry (Ex. 587  nm, Em. 612  nm). After blank correction 
(PBS background), raw fluorescence data was normalized 
by dividing F by the OD600 of the cell suspensions (200  μl) 
measured in a Benchmark Plus microplate spectrophotometer 
(Bio-Rad).
Statistical Analysis
When indicated, differences were assessed by one-tailed t-test 
as implemented in Microsoft Excel 2010 (2010 Microsoft 
Corporation) and p  <  0.05 was considered to be  significant.
RESULTS
Resistance of Lcn972R L. lactis Mutants to 
AMPs Other Than Lcn972
In our previous work, three Lcn972 resistant mutants (Lcn972R) 
L81-D1, L81-E2, and L62-G9 (Table  1) were isolated after 
continuous exposure of the wild-type (WT) strains L. lactis 
subsp. lactis L81 and L. lactis subsp. lactis L62 to subinhibitory 
concentrations of the cell wall-active bacteriocin Lcn972. The 
preliminary phenotypic characterization already suggested that 
the two mutants L81-E2 and L62-G9 displayed cross-resistance 
to bacitracin, while L81-D1 was more susceptible than its 
parent L. lactis L81 (López-González et  al., 2018). Standard 
MIC determinations confirmed that bacitracin MICs for L81-E2 
and L62-G9 increased by 8- and 4-fold, respectively, whereas 
the MIC for L. lactis L81-D1 was reduced 2-fold (Table  2). 
MICs of other antimicrobials such as nisin and  vancomycin 
also increased 2- or 4-fold for some Lcn972R mutants (Table 2) 
in line with our previous results (López-González et  al., 2018).
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Presence of a BceAB-Like Detoxification 
Module in L. lactis
Three Lcn972R mutants L81-D1, L81-E2, and L62-G9 carried, 
among others, non-synonymous mutations in ysaB, a gene coding 
for the permease of a putative ABC transporter (López-González 
et  al., 2018). Inspection of the genome of the WT strains L81 
and L62 (European Nucleotide Archive under accession number 
ENA: PRJNA 492214) and the laboratory strain L. lactis subsp. 
lactis IL1403 (GenBank AE005176.1) revealed that ysaB is flanked 
by ysaC and genes encoding the TCS-G (Figure  1A). YsaC 
contains the ATP-binding domain and YsaB shares the features 
of BceB-like permeases with 10 transmembrane helices (TMHs) 
and an extracellular loop (233 aa), according to TMpred1 and 
Psort2 predictions. All the ysaB mutations detected in the Lcn972R 
strains mapped in the C-terminus. Three mutations (F577V, F577S, 
and I594F) were found in the predicted inside loop between 
TMH VIII and IX. The additional mutation P605T detected in 
L. lactis L81-D1 was positioned within TMH IX. The genes 
encoding the TCS-G with the response regulator LlrG and the 
intramembrane histidine kinase KinG are located downstream 
of ysaB (Figure  1A). This genetic arrangement is similar to 
that found for other BceAB-like ABC transporters which are 
genetically linked to regulatory elements such as TCSs and 
involved in resistance to AMPs (Dintner et  al., 2011).
Additional genes (ysaD and ysaA) were also identified 
(Figure 1A). Homology and conserved domain searches identified 
YsaD (119 aa) as a member of TIGR01655 (uncharacterized 
protein YxeA), a family of small uncharacterized secreted 
proteins which are found exclusively in Gram-positive bacteria. 
YsaA (354 aa) is predicted to be an integral membrane protein 
with nine TMHs. It contains a VanZ domain present in 
glycopeptide antibiotic resistance proteins (pfam04892), denoting 
a possible role in resistance to AMPs.
The module YsaDCB/TCS-G is present in 41 out of the 
192 complete L. lactis genomes deposited at NCBI (as of June 
2020) according to BLASTN3 searches, and it seems highly 
conserved (over 80% identity at the nucleotide level) within 
the two L. lactis subspecies cremoris and lactis. It is worth 
mentioning that, in the laboratory workhorse strain L. lactis 
MG1363 and its derivative L. lactis NZ9000, the ABC transporter 
appears to be  nonfunctional due to a stop codon at position 
310 that created a truncated YsaB permease of 103 residues. 
Otherwise, its TCS-G is complete. A detailed comparison at 
the protein level and accession numbers is included in 
Supplementary Table  2.
The Putative Detoxification Module 
YsaDCB/TCS-G in L. lactis Is Transcribed 
in Two Polycistronic mRNAs
The genes of the putative Ysa-TCS-G module are transcribed 
in two polycistronic mRNAs as determined by RT-PCR 




Based  on  the amplification results, two mRNAs ysaDCB and 
ysaA-llrG-kinG-tyrA are synthesized. Consistent with this, two 
putative promoters could be identified upstream of ysaD (PysaD) 
and ysaA (PysaA), as well as three rho-independent terminators 
downstream of aroC, ysaB, and tyrA (Figure  1B). A positive 
PCR amplification of the intergenic region kinG-tyrA was 
detected, which could be  due to the presence of a putative 
promoter at the 3' end of kinG, upstream of the forward primer 
used in RT-PCR (Figure  1B). The flanking genes tyrA and 
aroC coding for prephenate dehydrogenase and chorismate 
synthase, respectively, are involved in the biosynthesis of aromatic 
amino acids. Hence, it is unlikely that they participate in the 
transport and/or sensing functions of the YsaDCB/
TCS-G module.
ysaDCB but Not TCS-G Genes Are Highly 
Expressed in Lcn972R L. lactis Mutants
Bearing in mind the role of BceAB-like transporters in resistance 
to AMPs, the expression levels of ysaDCB, ysaA, llrG, and 
kinG were determined in exponentially growing cultures of 
the L. lactis Lcn972R mutants by RT-qPCR. The expression 
of the TCS-G genes was not altered in any of the mutants. 
On the contrary, ysaDCB were upregulated in the Lcn972R 
mutants albeit to a different extent. Highest expression occurred 
in L. lactis L81-E2 (close to 20-fold), followed by L. lactis 
A
B
FIGURE 1 | Operon organization of the Ysa TCS-G module in Lactococcus 
lactis. (A) Overview of the ysa and flanking genes (open arrows). Promoters 
are depicted as black arrows and terminators as lollypops. Predicted 
transmembrane helices are shown as dark gray strips. Localization of ysaB 
mutations is marked with an asterisk (*). The two predicted mRNAs are 
displayed by dot-end arrows. Intergenic regions (1–5) amplified by RT-PCR 
are shown by dot-end lines. (B) RT-PCR amplified bands (1–5) using as 
template cDNA, RNA (negative control), and genomic DNA (positive control) 
from L. lactis L81.
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A
B
FIGURE 3 | Resistance to bacitracin (A) and Lcn972 (B) of L. lactis NZ9000 
clones expressing the different versions of ysaDCB genes. Calculated IC50 
values are displayed inside the bars. Average and SD from, at least, two 
independent IC50 determinations are shown. Values with different letters are 
significantly different (p < 0.05).
L62-G9 (up to 10-fold; Figure  2). In L. lactis L81-D1, which 
carries two ysaB mutations (F577S and P605T) and is sensitive 
to bacitracin, the expression of ysaDCB was lower but still 
up to 5-fold compared to the WT L. lactis L81 (Figure  2). 
Closer inspection and resequencing of the PCR-amplified PysaD 
promoter in all these strains did not show any anomalies, 
which could explain the higher expression levels of the ysaDCB 
operon in the Lcn972R mutants.
Further confirmation of the increased expression of the 
ysaDCB genes in the Lcn972R L. lactis mutants was gathered 
by monitoring the functional expression of the fluorescent 
mCherry protein gene mrfp placed under the control of the 
PysaD promoter in the reporter plasmid pRCR_PysaD::mrfp. While 
hardly any fluorescence could be measured in both exponential 
and stationary phase cultures of L. lactis L81, fluorescence was 
30-fold and 10-fold higher in L. lactis L81_E2 and L. lactis 
L81_D1 (Supplementary Figure S1A).
Of note, the expression levels of ysaDCB mirrored resistance 
to Lcn972 but not to bacitracin (Table 2). Despite their increased 
expression in L. lactis L81-D1, this mutant was more sensitive 
to bacitracin than the WT. Moreover, different susceptibility 
to bacitracin was also noticed within the laboratory strains 
L. lactis IL1403, with a complete YsaDCB transporter, and 
L. lactis NZ9000 that lacks a functional YsaB permease, being 
4-fold more resistant to bacitracin than IL1403. These 
observations suggest that bacitracin resistance mechanisms other 
than YsaDCB are functional in L. lactis.
Mutated Versions of ysaB Provide Distinct 
Resistance Levels to Bacitracin and 
Lcn972
In order to confirm the suspected role of the YsaDCB transporter 
in bacitracin and Lcn972 resistance and assess the impact of 
the ysaB mutations, the WT and mutated ysaB genes were 
cloned under the inducible nisin promoter (plasmids pDCB_n) 
and expressed in the L. lactis NZ9000 background (ysaB deficient). 
In this way, the level of protection provided by the ABC 
transporter itself and its mutated versions could be  assessed 
and compared within the same genetic background, independently 
of their own regulation and the other mutations present in the 
Lcn972R mutants. The transporter genes of L. lactis IL1403 
were also cloned (pDCB_IL) because they have been previously 
linked to nisin resistance (Kramer et  al., 2006). Dose-response 
curves showed that expression of the WT genes ysaDCB of 
L. lactis L81 and L. lactis IL1403 conferred a 5-fold increase 
in the bacitracin and Lcn972 concentration required to inhibit 
growth by 50% (IC50), as compared to the control with the 
empty vector pUK200 (Figure  3). Hence, the role of YsaDCB 
in resistance of L. lactis to both AMPs was confirmed.
In the case of the mutated alleles of ysaB, represented by 
the ysaDCB operons from L81-D1, L81-E2, and L62-G9 (the 
WT ysaDCB from L. lactis L62 is identical to L81), contribution 
to resistance varied depending on the AMP (Figure  3). In 
line with the MICs reported in Table 2, the double ysaB mutant 
transporter pDCB_D1 failed to protect against bacitracin as 
judged by the low IC50 values, similar to those with the control 
L. lactis pUK200. On the contrary, the transporters in pDCB_E2 
FIGURE 2 | Relative expression of Ysa and TCS-G genes in the L. lactis 
Lcn972R mutants determined by RT-qPCR. Relative gene expression was 
determined by the 2−ΔΔCt method using the WT strains L. lactis L81 (for 
L81-D1 and L81-E2) and L. lactis L62 for L62-G9 as reference. Average of 
three biological replicates and SD (error bars) are shown.
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and pDCB_G9 provided similar levels of protection as the 
WT transporter. As for resistance to Lcn972, the scenario was 
different. Regardless of the ysaB allele, all the transporters 
boosted protection against Lcn972 over the WT genes (p < 0.05; 
Figure 3 IC50), with pDCB_G9 being less effective than pDCB_D1 
and pDCB_E2 (p  <  0.05). These results suggest that the 
mechanisms whereby YsaDCB protects L. lactis against bacitracin 
and Lcn972 might differ.
ysaB Mutations Trigger the PysaD Promoter 
in the Absence of Bacitracin
A mutagenesis study of the BceSR/BceAB resistance module 
has shown that single amino acid substitutions in the B. subtilis 
permease BceB may have different consequences in either 
signaling or resistance (Kallenberg et  al., 2013). Moreover, 
the authors observed that those mutations that primarily affect 
the activity of the transporter tend to cluster in the C-terminal 
of the permease, which is the case with the ysaB mutations 
identified in the Lcn972R L. lactis mutants (see Table  1). 
Therefore, we  next investigated if the mutations in ysaB, 
besides affecting resistance, could also alter onward signal 
transmission through the TCS-G and lead to induction of 
the ysaDCB operon upon detection of the stress. With this 
aim, bacitracin was chosen to measure PysaD promoter activity 
due to the different resistance levels provided by the ysaB 
alleles (see Figure  3A). We  first confirmed that PysaD was 
silent (OFF-state) in L. lactis NZ9000 lacking ysaB, even in 
the presence of bacitracin. As shown in Supplementary 
Figure S1B, while mCherry fluorescence in L. lactis IL1403/
pRCR_PysaD::mrfp increased proportionally to increasing 
bacitracin concentration, there was no response in L. lactis 
NZ9000/pRCR_PysaD::mrfp. Therefore, L. lactis NZ9000 was 
deemed as a suitable host to study the signaling ability of 
YsaDCB and the existence of any other mechanisms that 
could induce PysaD was ruled out.
To quantify the activity of the PysaD promoter in the L. lactis 
NZ9000 pDCB_n clones expressing the different ysaB alleles, 
the reporter plasmid pPysaD::lacZ was constructed in which a 
Tet resistance marker is present to help keeping both pDCB_n 
and reporter plasmids in L. lactis NZ9000. Although the 
β-galactosidase assay was not sensitive enough to detect activation 
of PysaD in the presence of pDCB_IL, the promoter was responsive 
to bacitracin when the L. lactis L81 ysa genes (pDCB_L81) 
were expressed (Figure  4). Hence, it was possible to compare 
signaling driven by the different ysaB alleles. Under non-inducing 
conditions, L. lactis NZ9000 expressing the mutated ysaB 
transporters exhibited a higher PysaD basal activity than that 
achieved with the WT transporter YsaDCB_L81 (p  <  0.05). 
This basal activity was remarkably high in the presence of 
YsaDCB_E2 and YsaDCB_G9 transporters (Figure  4). Besides 
this apparent deregulation, the PysaD promoter was still induced 
by bacitracin, although the level of response was clearly 
diminished in relation to the WT transporter. In this latter 
case, β-galactosidase activity rose by 5-fold after the challenge 
with bacitracin at 5  μg/ml, whereas it only increased 1.2-fold 
in the presence of YsaDCB_D1 and 1.5-fold and in the presence 
of the other two mutated transporters.
The Secreted Peptide YsaD Seems to 
Modulate the Activity of the YsaDCB/
TCS-G Module
The fact that ysaD forms an operon with ysaCB and that it 
is conserved within L. lactis raised the question whether this 
secreted peptide was somehow required for proper functioning 
of the YsaDCB/TCS-G module. Bearing in mind the dual role 
of the transporters in resistance and signal relay, we  initially 
determined the IC50 values of bacitracin and Lcn972 for L. lactis 
NZ9000 expressing ysaCB from L. lactis IL1403 (pCB_IL) or 
from L. lactis L81 (pCB_L81) and compared to those 
expressing  the whole cluster ysaDCB (Table  3). YsaD appears 
FIGURE 4 | Induction of PysaD by bacitracin. Exponentially growing L. lactis NZ9000 clones expressing the different versions of ysaDCB genes (pDCB_n) and 
carrying the reporter plasmid pPysaD::lacZ were challenged with varying concentrations of bacitracin (Bac) for 30 min. Average and SD from three independent 
experiments are shown. Values with different letters are significantly different (p < 0.05).
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FIGURE 5 | Induction of PysaD in the presence of pDCB_n and pCB_n. Exponentially growing L. lactis NZ9000 clones expressing the full ysaDCB (DCB_n) operon 
or ysaCB (CB_n) lacking ysaD from L. lactis L81 (L81) or L. lactis IL1403 (IL) and the reporter plasmid pIL_PysaD::mrfp were challenged with bacitracin at 5 and 1 μg/
ml for 30 min before mCherry fluorescence (F) was measured.
to be  dispensable for resistance. All the clones were more 
resistant to bacitracin and Lcn972, compared to the control 
with the empty vector, and showed comparable bacitracin and 
Lcn972 IC50 values regardless the presence of ysaD. Only 
L. lactis NZ9000 pCB_L81 exhibited a 2-fold increase in the 
bacitracin IC50, compared to pDCB_L81, suggesting a possible 
but marginal role of ysaD in resistance.
We also measured PysaD activity in the absence of ysaD to 
assess if YsaD could interfere with signal relay. Due to the 
low sensitivity of the lacZ reporter, unable to reveal induction 
of the PysaD promoter by the L. lactis IL1403 YsaDCB transporter, 
a more sensitive reporter plasmid pIL_PysaD::mrfp, based on 
the mCherry fluorescent protein, was used. This reporter was 
transferred to L. lactis NZ9000 pDCB_n and pCB_n clones. 
As shown in Figure  5, induction of PysaD by bacitracin in the 
presence of pDCB_IL could be demonstrated, albeit the response 
was roughly 10-fold lower than with pDCB_L81 (Figure  5). 
When the activity of PysaD was compared in the absence and 
presence of ysaD after the addition of bacitracin, the results 
were different depending on the transporter. The PysaD promoter 
was turned down in L. lactis NZ9000/pCB_L81, while it was 
strongly induced in L. lactis NZ9000/pCB_IL (Figure  5). This 
apparently incongruent behavior must rely on subtle differences 
within the L81 and IL1403 ABC transporters that could 
be  important for the interaction with the L. lactis NZ9000 
TCS-G (see section Discussion). Nonetheless, YsaD appears 
to modulate the activity of the YsaDCB/TCS-G module by 
altering signal relay. Finally, it is worth noting that attempts 
to show induction of PysaD by Lcn972 failed. All the reporter 
strains with either pDCB_n or pCB_n were exposed to Lcn972 
at 80, 40, and 20  AU/ml, but fluorescence was never detected 
(data not shown).
DISCUSSION
The L. lactis YsaDCB ABC transporter is proposed to form 
a functional AMP detoxification module with the adjacent 
TCS-G, based on the genetic organization and the domain 
architecture of both the permease YsaB and the intramembrane-
sensing histidine kinase KinG, two landmarks shared among 
AMP  resistance modules in Firmicutes (Dintner et  al., 2011; 
Gebhard, 2012). Accordingly, we  have shown that increased 
expression of ysaDCB confers resistance against bacitracin and 
Lcn972  in L. lactis and that the module does not respond to 
bacitracin in the absence of a functional ABC transporter.
Previous studies have also linked this ABC transporter to 
nisin resistance in L. lactis (Kramer et  al., 2006). Thereby, 
YsaDCB/TCS-G is able to provide resistance to cationic AMPs 
that differ in their mode of action. This is similar to other 
modules such as the staphylococcal GraXSR/VraFG and BraRS/
BraDE reviewed by Kawada-Matsuo et  al. (2011), whereas in 
B. subtilis the different Bce-like modules seem to be  more 
specialized for bacitracin (BceSR/BceAB), nisin and other lipid 
II-binding lantibiotics (PsdRS/PsdAB) or cationic peptides such 
as the human defensin LL-37 (YxdJK/YxdLM-YxeA; Staron 
et  al., 2011). The reason likely relies on the scope of the genes 
which are regulated by these resistance modules. Some modules 
only regulate the ABC transporter genes (e.g., BceSR/BceAB), 
while others (e.g., GraXSR/VraFG) include genes such as the 
dlt operon and mprf involved in d-alanylation of lipoteichoic 
acids and lysylination of phosphatidylglycerol, respectively, that 
TABLE 3 | IC50 valuesa for L. lactis NZ9000 expressing ysaCB.






aAverage ± standard deviation of, at least, two independent biological replicates are 
shown.
bIC50 values are also shown in Figure 3 but are included here for comparison.
*p < 0.05, significant difference between pDCB_L81 vs. pCB_L81. For all clones, 
bacitracin and Lcn972 IC50 are increased in comparison with L. lactis NZ9000 with the 
empty vector pUK200.
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contribute to AMP resistance by decreasing the net negative 
charge of the bacterial surface. BraRS/BraDE and VirSR/VirAB 
also regulate the expression of other ABC transporters such 
as VraDEH in S. aureus and AnrAB in Listeria monocytogenes, 
respectively. These transporters likely function as a “hydrophobic 
vacuum cleaner,” removing the AMPs out of their site of action 
(Collins et  al., 2010; Hiron et  al., 2011).
Our results have demonstrated that point mutations in ysaB 
activate the YsaDCB/TCS-G module. PysaD is active in the 
absence of bacitracin, when the mutated ysaB alleles are expressed 
in L. lactis NZ9000 and not in the case of the WT transporters. 
Gain-of-function mutations in the Bra(Nsa)SR/BraDE module 
have been mapped on braS or braR or on the TCS promoter 
in nisin-resistant S. aureus (Randall et  al., 2018; Arii et  al., 
2019), but there are also examples in which mutations in the 
permease gene enhance resistance by inducing the expression 
of the ABC-transporter genes (Becker et  al., 2009). In view 
of the current flux sensing model (Fritz et  al., 2015), one 
possible explanation could be  that the permease mutations 
reduce the activity of the YsaDCB transporter. This scenario 
would impose more pressure onto the system to increase the 
rate of de novo transporter synthesis and get more transporter 
molecules to relieve the stress. However, it is difficult to explain 
the constitutive expression in the absence of the AMP and 
the loss of responsiveness to AMP concentration, as observed 
with the mutated YsaDCB transporters. Moreover, since flux 
sensing relies on ATP hydrolysis, it would be clearly deleterious 
for the cells. Alternatively, the mutations in the YsaB permease 
could modify protein-protein interactions within the module, 
triggering activation of the histidine kinase, irrespectively of 
the activity of the YsaDCB transporter. Recently, it has been 
proposed that the ABC transporter BraDE, beyond its role in 
sensing and activation of BraSR regulon, also enables onward 
signal transduction through the histidine kinase BraS in some 
way, which is independent of ATP consumption (Randall et al., 
2018). This role was proposed after observing that the 
nisin-resistant phenotype of a gain-of-function braS mutant 
lacking braDE could be  complemented with an ATP-deficient 
braDE copy. In this scenario, it is conceivable that mutations 
in the permease could prompt activation of the TCS. However, 
further biochemical evidence is required to prove if this is 
the case of the ysaB mutations.
Increased expression of ysaDCB-D1 was not enough to 
confer resistance to bacitracin, whereas protection against 
Lcn972 was enhanced compared to the WT YsaDCB transporter. 
This takes us to speculate that YsaDCB may protect L. lactis 
by two different means. For bacitracin, it has been proposed 
that the B. subtilis BceAB transporter binds to the complex 
bacitracin-undecaprenyl pyrophosphate and releases the 
antibiotic from it, freeing the cell wall precursor to proceed 
with cell wall biosynthesis (Kobras et  al., 2020). The double 
amino acid substitution F577S/P605T in YsaB-D1 could make 
the ABC transporter less efficient for bacitracin release, and 
thus unable to protect against bacitracin. Kobras et  al. (2020) 
also hypothesize that a similar target protection mechanism 
should also work for lipid II binding peptides such as mesarcidin 
and actagardine. However, YsaDCB-D1 is as effective as 
YsaDCB-E2 against Lcn972. Since YsaDCB-D1 is still competent 
to trigger activation of the module, we speculate that downstream 
activities (i.e., other functions regulated by the YsaDCB/TCS-G 
module) are responsible for resistance to Lcn972. In support 
of this hypothesis, motif-based searches, using the consensus 
binding sequence for BceR-like response regulators proposed 
by Dintner et  al. (2011), detected a putative BceR-binding 
box in the promoter of the dlt genes in L. lactis. Moreover, 
d-alanylation of lipoteichoic acids is known to constitute an 
Lcn972 resistance factor (Roces et  al., 2012).
The L. lactis BceAB-like transporter is equipped with an 
additional protein YsaD whose structural gene is co-transcribed 
with ysaCB. According to BlastP searches, YsaD belongs to 
the family TIGR01655 of small uncharacterized proteins with 
N-terminal signal sequences, conserved in Gram-positive 
organisms. These properties are shared with YxeA, in the B. 
subtilis module YxdJK/YxdLM-YxeA (Joseph et  al., 2004), but 
its putative function has not been addressed so far. Our results 
suggest that these proteins may play an accessory role, modulating 
the activity of the transporter and/or governing signal 
transduction through protein-protein interactions within the 
module. Despite having an identical YsaD, removal of this 
protein had two opposite effects: a drop of signaling in the 
case of the transporter YsaDCB-L81 and boosting the otherwise 
poor ability of the L. lactis IL1403 transporter to activate 
L. lactis NZ9000 TCS-G (see Figure  5). Being aware that our 
experimental setup is not the best scenario to interrogate for 
fine tuning or regulatory feedback, simply because it relies on 
the formation of a heterologous ABC/TCS module, this 
discrepancy could be  explained when specific YsaD-YsaB or 
YsaD-YsaB-KinG interactions regulate transport activity and 
that such interactions differ within these two transporters. Both 
YsaDCB-L81 and YsaDCB-IL are highly homologous with only 
one non-conservative amino acid substitution in the ATP-binding 
protein YsaC (E139 in L81 and K139 in IL1403), outside the 
conserved protein domains and unlikely to interfere with 
transport activity. The other one is in the YsaB permease (K621 
in L81 and E621 in IL1403). This position is predicted to 
be  located at the external linker between the last two TMHs 
IX and X. From our results and others (Kallenberg et  al., 
2013), it is known that single amino acid substitutions in the 
permease, namely, in the C-terminus, may severely alter signal 
transduction. Consistent with this, there is a 10-fold difference 
in the ability of the IL1403 and L81 transporters to trigger 
the PysaD promoter in response to bacitracin. ABC connectors 
or accessory proteins such as the cytosolic GraX and the small 
membrane protein VraH have already been described (Falord 
et  al., 2012; Popella et  al., 2016). Whether the same applies 
for a soluble and likely secreted peptide remains to 
be  investigated. It is worth mentioning that in L. lactis there 
is an additional gene, ysaA, which is co-transcribed with the 
TCS-G gene and specifies for a transmembrane protein. YsaA, 
as yet unique to L. lactis, is likely to play a role in the 
transduction pathway too.
There was another result that will require further attention. 
Under the experimental conditions used in this work, we  were 
unable to detect activation of PysaD by Lcn972, which is known 
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to bind to lipid II as many other Bce-like inducers. In a way, 
this was unexpected given that the gain-of-function mutations 
in ysaB were selected under the stress imposed by this bacteriocin 
(López-González et  al., 2018). However, YsaDCB/TCS-G is 
likely regulating the dlt operon, which should protect against 
Lcn972 and, thereby, growth of gain-of-function mutants would 
be expedited. At this stage, it is difficult to propose a reasonable 
explanation for the lack of induction by Lcn972. We  cannot 
disregard a host effect, i.e., that Lcn972 is unable to trigger 
the response in L. lactis NZ9000 but in other strain backgrounds, 
as recently observed with VirAB/VirRS in L. monocytogenes 
(Grubaugh et  al., 2018; Jiang et  al., 2019).
In conclusion, we  have shown that YsaDCB/TCS-G 
participates in AMP resistance in L. lactis anticipating 
alternative mechanisms of resistance against different AMPs. 
Specific mutations which are easily selected under cell envelope 
stress have been shown to activate the module constitutively. 
Moreover, YsaDCB/TCS-G seems to be  unique as to the 
intricate regulatory circuits due to the presence of additional 
proteins that modulate its activity, thereby warranting further 
research to understand these important resistance factors 
and their contribution to antimicrobial resistance. While for 
a nonpathogenic bacterium such as L. lactis antibiotic resistance 
may not be  an issue of concern so far, this study opens 
new avenues for developing biotechnologically proficient 
strains able to withstand better the presence of bacteriocins 
or other  cationic antimicrobials as lysozyme, currently in 
use as preservatives in food.
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